Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging

NCT01221272 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Perfusion Imaging
Myocardial Ischemia

Interventions

DRUG: Ranolazine
DRUG: Placebo to match ranolazine
PROCEDURE: SPECT MPI
BEHAVIORAL: Exercise

Sponsor

Gilead Sciences